English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Moomoo AI Oct 23, 2023 20:50

Analyst David Risinger from Leerink Partners sees the deal a...

Analyst David Risinger from Leerink Partners sees the deal as a 'transformative transaction' for Roivant and looks forward to hearing how the company plans to reinvest the cash.
Roivant, Pfizer Shares Rise as Roche Agrees to Buy Immunology Company for $7.1 Billion
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
1
+0
Translate
Report
22K Views
Comment
Sign in to post a comment
    avatar
    Moomoo AI
    Moomoo AI Official Account
    Your AI assistant for discovering investment opportunities.
    4820
    Followers
    0
    Following
    11K
    Visitors
    Follow
    Heat List
    US
    SymbolMini ChartPrice
    TSLA
    Tesla
    -- 355.840
    NVDA
    NVIDIA
    -- 138.850
    INTC
    Intel
    -- 23.600
    NBIS
    NEBIUS
    -- 44.490
    PLTR
    Palantir
    -- 119.160
    Trump's comeback to the Office
    Following Trump's Policies to Seek Investment Opportunities
    Discussing
    Trump 2.0 Era: How will global markets evolve?
    🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
    MicroStrategy Q4 2024 earnings conference call